- Home
- OVV vs AXSM Comparison
OVV vs AXSM Comparison
Compare OVV & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OVV | AXSM |
|---|---|---|
| Founded | 2020 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 9.0B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | OVV | AXSM |
|---|---|---|
| Price | $38.83 | $167.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 20 |
| Target Price | $49.50 | ★ $183.10 |
| AVG Volume (30 Days) | ★ 3.2M | 690.1K |
| Earning Date | 02-25-2026 | 02-17-2026 |
| Dividend Yield | ★ 3.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $8,794,000,000.00 | $561,263,000.00 |
| Revenue This Year | N/A | $66.40 |
| Revenue Next Year | $1.67 | $56.13 |
| P/E Ratio | $41.06 | ★ N/A |
| Revenue Growth | N/A | ★ 65.83 |
| 52 Week Low | $29.80 | $79.19 |
| 52 Week High | $46.35 | $184.40 |
Technical Indicators
Market Signals| Indicator | OVV | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 49.73 | 60.12 |
| Support Level | $36.81 | $168.58 |
| Resistance Level | $40.87 | $184.40 |
| Average True Range (ATR) | 1.21 | 6.75 |
| MACD | -0.05 | 1.26 |
| Stochastic Oscillator | 49.94 | 55.48 |
Price Performance
Historical ComparisonAbout OVV Ovintiv Inc. (DE)
Ovintiv Inc is a North American oil and natural gas exploration and production company that is focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs and natural gas. The company has two operating segments: USA Operations, and Canadian Operations. The USA Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within the United States. The Canadian Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within Canada.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.